Valuation check: OMER's debt-to-equity ratio is -1.63, below the Healthcare sector average of 0.3.
Get informed when a big investor buys or sells
+ Follow-1.63
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
Omeros (OMER) currently reports a debt-to-equity ratio of -1.63. That is below the Healthcare sector average of 0.3. Use the charts on this page to explore Omeros's debt-to-equity ratio history and peer comparisons.
Omeros's debt-to-equity ratio of -1.63 is lower than the Healthcare sector average of 0.3. That is roughly 642.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The debt-to-equity ratio is a valuation multiple that relates Omeros's market price to a fundamental measure such as earnings, sales, or book value. At -1.63, OMER can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current debt-to-equity ratio of -1.63, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 0.3. From there, open related valuation or income-statement pages for Omeros, and consider following OMER for alerts when major investors trade the stock.
Omeros is classified in the Healthcare sector. On debt-to-equity ratio, it currently shows -1.63 versus a sector average near 0.3. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OMER with unrelated industries.